166 related articles for article (PubMed ID: 2069564)
1. Phosphoramidon inhibits the conversion of intracisternally administered big endothelin-1 to endothelin-1.
Shinyama H; Uchida T; Kido H; Hayashi K; Watanabe M; Matsumura Y; Ikegawa R; Takaoka M; Morimoto S
Biochem Biophys Res Commun; 1991 Jul; 178(1):24-30. PubMed ID: 2069564
[TBL] [Abstract][Full Text] [Related]
2. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat.
Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
Life Sci; 1994; 55(16):1285-91. PubMed ID: 7934630
[TBL] [Abstract][Full Text] [Related]
3. Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1.
Matsumura Y; Hisaki K; Takaoka M; Morimoto S
Eur J Pharmacol; 1990 Aug; 185(1):103-6. PubMed ID: 2226629
[TBL] [Abstract][Full Text] [Related]
4. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
[TBL] [Abstract][Full Text] [Related]
5. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
[TBL] [Abstract][Full Text] [Related]
6. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
[TBL] [Abstract][Full Text] [Related]
7. Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid.
Matsumura Y; Ikegawa R; Suzuki Y; Takaoka M; Uchida T; Kido H; Shinyama H; Hayashi K; Watanabe M; Morimoto S
Life Sci; 1991; 49(11):841-8. PubMed ID: 1875792
[TBL] [Abstract][Full Text] [Related]
8. Conversion of big endothelin-1 to endothelin-1 by phosphoramidon-sensitive metalloproteinase derived from aortic endothelial cells.
Matsumura Y; Ikegawa R; Hisaki K; Tsukahara Y; Takaoka M; Morimoto S
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S65-7. PubMed ID: 1725435
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
[TBL] [Abstract][Full Text] [Related]
10. Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats.
Matsumura Y; Fujita K; Takaoka M; Morimoto S
Eur J Pharmacol; 1993 Jan; 230(1):89-93. PubMed ID: 8094056
[TBL] [Abstract][Full Text] [Related]
11. Human big endothelin releases prostacyclin in vivo and in vitro through a phosphoramidon-sensitive conversion to endothelin-1.
D'Orléans-Juste P; Lidbury PS; Telemaque S; Warner TD; Vane JR
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S251-5. PubMed ID: 1725347
[TBL] [Abstract][Full Text] [Related]
12. Evidence for phosphoramidon-sensitive conversion of big endothelin-1 to endothelin-1 in isolated rat mesenteric artery.
Hisaki K; Matsumura Y; Ikegawa R; Nishiguchi S; Hayashi K; Takaoka M; Morimoto S
Biochem Biophys Res Commun; 1991 Jun; 177(3):1127-32. PubMed ID: 2059203
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery.
Schilling L; Vatter H; Mursch K; Ehrenreich H; Schmiedek P
Peptides; 2000 Jan; 21(1):91-9. PubMed ID: 10704724
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence for the presence of a phosphoramidon-sensitive enzyme in rat brain that converts big endothelin-1 to endothelin-1.
Hashim MA; Tadepalli AS
Life Sci; 1991; 49(24):PL207-11. PubMed ID: 1943480
[TBL] [Abstract][Full Text] [Related]
15. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
[TBL] [Abstract][Full Text] [Related]
17. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
[TBL] [Abstract][Full Text] [Related]
18. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney.
Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848
[TBL] [Abstract][Full Text] [Related]
19. Contractile effect of big endothelin-1 and its conversion to endothelin-1 in rabbit cerebral arteries.
Petersson J; Hanson GC; Lindberg BF; Högestätt ED
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):656-61. PubMed ID: 8938666
[TBL] [Abstract][Full Text] [Related]
20. Possible role of endothelin in the pathogenesis of cerebral vasospasm.
Shigeno T; Mima T; Yanagisawa M; Saito A; Fujimori A; Shiba R; Goto K; Kimura S; Yamashita K; Yamasaki Y
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S480-3. PubMed ID: 1725419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
